APLN and pulmonary arterial hypertension: Nevertheless, the apelin receptor is still present in PAH tissue (Andersen, Markvardsen, Hilberg, & Simonsen, 2009; Kim et al., 2013, Yang, Read, et al., 2017) and would therefore be available as a target for exogenous agonists to replace the missing apelin.